These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16995354)

  • 61. The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings.
    Currie CJ
    Diabetologia; 2009 Oct; 52(10):2234-5; author reply 2236-9. PubMed ID: 19662377
    [No Abstract]   [Full Text] [Related]  

  • 62. Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial.
    Tinahones FJ; Gross JL; Onaca A; Cleall S; Rodríguez A
    Diabetes Obes Metab; 2014 Oct; 16(10):963-70. PubMed ID: 24725616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Addition of insulin to oral therapy in type 2 diabetes.
    Ilag LL; Martin S; Jacober SJ
    N Engl J Med; 2008 Mar; 358(11):1197-8; author reply 1198. PubMed ID: 18340664
    [No Abstract]   [Full Text] [Related]  

  • 64. Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.
    Walczak IM
    Diabetes Technol Ther; 2002; 4(5):744-5. PubMed ID: 12458569
    [No Abstract]   [Full Text] [Related]  

  • 65. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.
    Mullins P; Sharplin P; Yki-Jarvinen H; Riddle MC; Haring HU
    Clin Ther; 2007 Aug; 29(8):1607-19. PubMed ID: 17919543
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.
    Janka HU; Plewe G; Busch K
    J Am Geriatr Soc; 2007 Feb; 55(2):182-8. PubMed ID: 17302653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
    ; Gerstein H; Yusuf S; Riddle MC; Ryden L; Bosch J
    Am Heart J; 2008 Jan; 155(1):26-32, 32.e1-6. PubMed ID: 18082485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical experiences with Lantus therapy in Swedish routine health care].
    Löndahl M; Nilsson A; Katzman P
    Lakartidningen; 2005 Sep 5-11; 102(36):2503, 2505. PubMed ID: 16196437
    [No Abstract]   [Full Text] [Related]  

  • 70. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine.
    Bretzel RG; Dippel FW; Linn T; Neilson AR
    J Med Econ; 2009 Jun; 12(2):87-97. PubMed ID: 19473110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients.
    Hirsch IB; Yuan H; Campaigne BN; Tan MH
    Endocr Pract; 2009; 15(4):343-8. PubMed ID: 19454394
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Basal insulin supplementation in type 2 diabetes; refining the tactics.
    Rosenstock J
    Am J Med; 2004 Feb; 116 Suppl 3A():10S-16S. PubMed ID: 15013455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?
    Ann Intern Med; 2011 Jan; 154(2):I-40. PubMed ID: 21135289
    [No Abstract]   [Full Text] [Related]  

  • 75. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine.
    Buse JB; Wolffenbuttel BH; Herman WH; Hippler S; Martin SA; Jiang HH; Shenouda SK; Fahrbach JL
    Diabetes Care; 2011 Feb; 34(2):249-55. PubMed ID: 21270182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [An update on multiple insulin injection therapy in type 1 and 2 diabetes].
    Varanauskiene E; Varanauskaite I; Ceponis J
    Medicina (Kaunas); 2006; 42(9):770-9. PubMed ID: 17028476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
    Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
    Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ["Very good metabolic control by early insulin administration"].
    Schumm-Draeger PM
    MMW Fortschr Med; 2012 Jun; 154(12):25. PubMed ID: 22880291
    [No Abstract]   [Full Text] [Related]  

  • 80. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
    Kawamori R; Kadowaki T; Ishii H; Iwasaki M; Iwamoto Y
    Diabetes Obes Metab; 2009 Sep; 11(9):891-9. PubMed ID: 19614947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.